FDA Enforcement
Class II
Ongoing
ARIES GBS Assay , REF 50-10021, UDI # 00840487100165
Recall: Z-2285-2019
·
Reported August 21, 2019
Enforcement
- Recall Number
- Z-2285-2019
- Event ID
- 83470
- Classification
- Class II
- Status
- Ongoing
- Product Type
- Devices
- Firm
- Luminex Corporation
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Report Date
- August 21, 2019
- Initiation Date
- February 20, 2019
- Classification Date
- August 15, 2019
- Address
- 12212 Technology Blvd, N/A, Austin, TX, 78727-6101, United States
Description
ARIES GBS Assay , REF 50-10021, UDI # 00840487100165
Reason
Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
Code Info
Lot numbers & discontinue use by dates for part number 50-10021: AA7546 - 3/9/2019 AA7629 - 4/10/2019
Distribution
US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom
Quantity
N/A